BR0308982A - Combinações de epinastina, beladona e pseudoefedrina como novas formulações farmacêuticas - Google Patents

Combinações de epinastina, beladona e pseudoefedrina como novas formulações farmacêuticas

Info

Publication number
BR0308982A
BR0308982A BR0308982-7A BR0308982A BR0308982A BR 0308982 A BR0308982 A BR 0308982A BR 0308982 A BR0308982 A BR 0308982A BR 0308982 A BR0308982 A BR 0308982A
Authority
BR
Brazil
Prior art keywords
pharmaceutically acceptable
acceptable salt
epinastine
amount
combinations
Prior art date
Application number
BR0308982-7A
Other languages
English (en)
Portuguese (pt)
Inventor
Noritaka Seko
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of BR0308982A publication Critical patent/BR0308982A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • Otolaryngology (AREA)
  • Immunology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BR0308982-7A 2002-04-03 2003-03-28 Combinações de epinastina, beladona e pseudoefedrina como novas formulações farmacêuticas BR0308982A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02007568A EP1350512A1 (en) 2002-04-03 2002-04-03 Combinations of epinastine, belladonna and pseudoephedrine as new pharmaceutical formulations
PCT/EP2003/003263 WO2003082285A1 (en) 2002-04-03 2003-03-28 Combinations of epinastine, belladonna and pseudoephedrine as new pharmaceutical formulations

Publications (1)

Publication Number Publication Date
BR0308982A true BR0308982A (pt) 2005-01-04

Family

ID=27838061

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0308982-7A BR0308982A (pt) 2002-04-03 2003-03-28 Combinações de epinastina, beladona e pseudoefedrina como novas formulações farmacêuticas

Country Status (12)

Country Link
US (1) US20030228359A1 (cg-RX-API-DMAC7.html)
EP (2) EP1350512A1 (cg-RX-API-DMAC7.html)
JP (1) JP2005522467A (cg-RX-API-DMAC7.html)
AR (1) AR039221A1 (cg-RX-API-DMAC7.html)
AU (1) AU2003221532A1 (cg-RX-API-DMAC7.html)
BR (1) BR0308982A (cg-RX-API-DMAC7.html)
CA (1) CA2477751A1 (cg-RX-API-DMAC7.html)
MX (1) MXPA04009582A (cg-RX-API-DMAC7.html)
PE (1) PE20040080A1 (cg-RX-API-DMAC7.html)
PL (1) PL371382A1 (cg-RX-API-DMAC7.html)
RU (1) RU2004132205A (cg-RX-API-DMAC7.html)
WO (1) WO2003082285A1 (cg-RX-API-DMAC7.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19954516A1 (de) * 1999-11-12 2001-05-17 Boehringer Ingelheim Int Epinastin-haltige Lösungen
US20030104017A1 (en) * 2001-10-26 2003-06-05 Boehringer Ingelheim International Gmbh Epinastine formulation for oral administration
KR20050092429A (ko) * 2003-01-22 2005-09-21 니찌방 가부시기가이샤 안질환 치료용 경피 흡수형 제제, 그 사용, 및 안질환치료약의 눈의 국소 조직으로의 이행 방법
JP2007517766A (ja) * 2003-09-24 2007-07-05 コンビナトアールエックス インコーポレーティッド 薬物の組み合わせを投与するための治療法
AU2005210086A1 (en) * 2004-02-06 2005-08-18 Meda Pharma Gmbh & Co. Kg Treatment of rhinitis with anticholinergics alone in combination with antihistamines phosphodiesterase 4 inhibitors, or corticosteroids
JP4936420B2 (ja) * 2005-08-02 2012-05-23 塩野義製薬株式会社 徐放性顆粒剤
JP5162141B2 (ja) * 2007-02-20 2013-03-13 エスエス製薬株式会社 フィルムコーティング用組成物
RU2366446C1 (ru) * 2008-06-27 2009-09-10 Сергей Анатольевич Небера Гомеопатическое средство для лечения конъюнктивитов
WO2010030418A1 (en) * 2008-09-10 2010-03-18 Micro-Dose Life Sciences Llc Anti-fever botanical composition and uses thereof
RU2567032C2 (ru) * 2009-05-01 2015-10-27 Апталис Фарматек, Инк. Перорально распадающиеся таблеточные композиции, содержащие комбинации неопиоидных и опиоидных анальгетиков
JP5852816B2 (ja) * 2010-09-10 2016-02-03 ロート製薬株式会社 液状医薬組成物、及びこれを含有する軟カプセル剤
RU2478377C1 (ru) * 2011-08-08 2013-04-10 Алексей Владимирович Брынцалов Комбинированный препарат орвиум для устранения симптомов простудных заболеваний и гриппа
CN110237079B (zh) * 2019-07-01 2021-05-14 山西大学 一种百部生物碱类似物的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10298107A (ja) * 1997-04-25 1998-11-10 Taisho Pharmaceut Co Ltd 医薬組成物
US6613357B2 (en) * 2000-01-13 2003-09-02 Osmotica Corp. Osmotic device containing pseudoephedrine and an H1 antagonist

Also Published As

Publication number Publication date
AR039221A1 (es) 2005-02-09
EP1350512A1 (en) 2003-10-08
PE20040080A1 (es) 2004-04-22
CA2477751A1 (en) 2003-10-09
PL371382A1 (en) 2005-06-13
AU2003221532A1 (en) 2003-10-13
MXPA04009582A (es) 2005-01-11
RU2004132205A (ru) 2005-09-10
US20030228359A1 (en) 2003-12-11
WO2003082285A1 (en) 2003-10-09
JP2005522467A (ja) 2005-07-28
EP1492532A1 (en) 2005-01-05

Similar Documents

Publication Publication Date Title
BRPI0314308B8 (pt) antagonistas de opióide, seus usos, e composição farmacêutica
BG106095A (bg) Нови лекарствени състави на базата на антихолинергично активни съединения и бета-миметици
JP2002069004A (ja) 末梢性活性抗痛覚過敏オピエート
NO20065638L (no) Formuleringer med kontrollert frigivelse inneholdende vardenafil
BR0112661A (pt) Nova combinação de agonista (5ht2) e antagonista (5ht6) da serotonina como formulação farmacêutica
NO20085271L (no) Muscarin reseptoragonister som er effektive i behandling av smerte, Alzheimers sykdom og schizofreni
BR9807950A (pt) Composto, composição farmacêutica, uso de um composto, e, processos para tratar ou reduzir o risco de doenças ou condições humanas, o risco de doença inflamatória o risco da dor e para a preparação de um composto
BR0317370A (pt) Composição farmacêutica e método paliativo
RU2006126638A (ru) АНТАГОНИСТЫ cdk2 В КАЧЕСТВЕ АНТАГОНИСТОВ КОРОТКОЙ ФОРМЫ ФАКТОРА ТРАНСКРИПЦИИ c-Maf ДЛЯ ЛЕЧЕНИЯ ГЛАУКОМЫ
CL2024003616A1 (es) Composición farmacéutica oral y uso para la terapia de enfermedades pulmonares intersticiales fibrosantes progresivas.
DE69333387D1 (de) Pharmazeutische Zusammensetzungen enthaltend Norastemizol.
ATE555807T1 (de) Catechine zur behandlung der fibrillogenese bei alzheimer-krankheit, parkinson-krankheit, systemischer aa-amyloidosis und anderer amyloid- störungen
DOP2005000039A (es) Hidrocloruro de [4-(5-aminometil-2-fluoro-fenil)- piperidin-1-il]-(4-bomo-3-metil-5-propoxi-tiofen-2-il)-metanona como un inhibidor de la triptasa de mastocitos
AR039221A1 (es) Combinaciones de epinastina, belladona y pseudoefedrina como formulaciones farmaceuticas
ES2773711T3 (es) Un metabolito de iloperidona para uso en el tratamiento de trastornos psiquiátricos
SE9902935D0 (sv) Pharmaceutical compositions
AR087240A2 (es) Composiciones farmaceuticas que tienen epinastina y pseudoefedrina
UY29823A1 (es) Derivados sustituidos de 7-cloro-3h-imidazol-(4,5-b) piridina, composiciones farmacéuticas que los contienen, procesos para la preparación de los mismos y aplicaciones
AR036009A1 (es) Composicion farmaceutica para el tratamiento o prevencion del dolor visceral y los trastornos gastrointestinales que comprenden un compuesto aminoácido biciclico y uso de este ultimo para fabricar dicha composicion farmaceutica
RU2005135649A (ru) Комбинации пароксетина и 4-(s)-(4-ацетилпиперазин-1-ил)-2-(r)-(4-фтор-2-метилфенил)пиперидин-1-карбоновой кислоты [1-(r)-(3, 5-бис-трифторметилфенил)этил]метиламида для лечения депрессии и/или тревоги
DE60019968D1 (de) Verwendung von gepirone metabolite zur erstellungs eines medicaments zur behandlung von neurologischer krankheiten
BR9810214A (pt) Composto, composição farmacêutica, uso de um composto, e, processos para tratar ou reduzir o risco de doenças ou condições humanas, para tratar ou reduzir o risco de doença inflamatória e de dor em uma pessoa sofrendo de ou sob risco de dita doença, de tratamento, e para a preparação de um composto
SE9900190D0 (sv) New compounds
BR0313175A (pt) Formulações farmacêuticas compreendendo combinações de epinastina, pseudoefedrina e metilefedrina
BR9808546A (pt) Composto, composição farmacêutica, uso de um composto, e, processos para tratar ou reduzir o risco de doenças ou condições do ser humano, tratar ou reduzir o risco de doença inflamatória e o risco da dor em uma pessoa que sofre, ou em risco, da dita doença e para a preparação do composto

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]